Daré Bioscience, Inc. (DARE) Social Stream



Daré Bioscience, Inc. (DARE): $1.52

-0.07 (-4.40%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add DARE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 459

in industry

Dare Bioscience Inc (DARE) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Dare Bioscience Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-08 5 $11 $3 $5.4 $1.59 239.62%

The Trend in the Analyst Price Target


DARE's average price target has moved up $0.4 over the prior 27 weeks.

DARE reports an average of 212.94% for its upside potential over the past 46 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-22 0 9 3 5.0 1.30 284.62%
2021-06-13 0 9 3 5.0 1.39 259.71%
2021-09-04 5 11 3 5.4 1.74 210.34%
2021-07-03 5 11 3 5.4 1.58 241.77%
2021-01-29 6 9 3 5.2 2.26 130.09%

DARE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


DARE's average broker recommendation rating improved by 0 over the prior 122 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for DARE as an investment opportunity.

  • To contextualize these metrics, consider that out of stocks in the micro market cap category, Dare Bioscience Inc's variance in analysts' estimates is lower than 0.63% of them.
  • DARE has a greater average analyst price target than 6.43% of Healthcare stocks.
  • Dare Bioscience Inc's number of analysts covering the stock is higher than 89.64% of stocks in the micro market cap category.
  • In terms of how Dare Bioscience Inc fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is higher than 67.61% of that group.

In the Pharmaceutical Products industry, CYCC, CWBR, and CPHI are the three stocks most similar to Dare Bioscience Inc regarding the price target and analyst recommendation information presented here.

Is DARE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6834 seconds.